Know Your Investor: Surveyor Capital (December’24 Edition) 

Shots:  A longstanding equities business within Citadel, Surveyor Capital invests in the consumer, financials, healthcare, industrials, and Technology, Media & Telecom sectors In 2023, Surveyor participated in four funding rounds, investing approximately $2.35B and adding 17 companies to its portfolio For a curated report on a specific investor or venture capital firm, reach out to…

ByPrince GiriDecember 5, 2024

INSIGHTS+

Know Your Investor: Catalio Capital Management (November’24 Edition)

Shots: A New York-based venture capital fund, Catalio Capital Management invests in breakthrough MedTech and innovative healthcare companies globally In 2023, Catalio Capital participated in eight funding rounds and invested approximately $1.82B to add 22 companies to its portfolio For a curated report on a specific investor or venture capital firm, reach out to us…

ByPrince GiriNovember 7, 2024

INSIGHTS+

Know Your Investor: Samsara Biocapital (October’24 Edition)

Shots: A California-based venture capital fund, Samsara Biocapital partners with medical companies and scientists to infuse cutting-edge innovations in medicines In 2023, Samsara participated in five funding rounds and invested around $2.3B to add 19 companies to its portfolio For a curated report on a specific investor or venture capital, reach out to us at connect@pharmashots.com …

ByPrince GiriOctober 17, 2024

INSIGHTS+

Know Your Investor: BVF Partners L.P. (September’24 Edition)

Shots: An equity hedge fund manager company, BVF Partners invests in small cap and early-stage biotechnology companies In 2023, BVF participated in five investment rounds and added 20 companies to its portfolio For a curated report on a specific investor or venture capital, reach out to us at connect@pharmashots.com Established in 1993 in San Francisco, California,…

ByPrince GiriSeptember 5, 2024

INSIGHTS+

Know Your Investor: Arch Venture Partners (August’24 Edition)

Shots: In the August Edition of the Know Your Investor series, we bring a condensed yet illuminating report on Arch Venture Partners In 2023, Arch Ventures Partners participated in 6 investment rounds and added 27 companies focusing on biopharma and manufacturing & services to its portfolio For a detailed report on all the investments, reach…

ByPrince GiriAugust 21, 2024

INSIGHTS+

Know Your Investor: Invus (July’24 Edition)

Shots:   Backed with an evergreen investment strategy, Invus makes investments across several company stages ranging from early growth to turnarounds In 2023, Invus participated in 6 investment rounds in around 29 companies focusing on biopharma, manufacturing & services, and devices For a curated report on a specific investor or venture capital, reach out to us…

ByPrince GiriJuly 17, 2024

INSIGHTS+

Know Your Investor (June Edition): Google Ventures

Shots: Google Ventures is an investment arm of Alphabet Inc. That invests profusely in seed-stage companies ranging from software and internet to healthcare, life sciences, and artificial intelligence among others Ever since 2016, GV pivoted to focusing on established companies. The company manages assets worth $10B and 400 active portfolio companies spanning across North America…

ByPrince GiriJune 13, 2024

INSIGHTS+

Know Your Investor (May Edition): Alexandria Venture Investment

Shots: In the May Edition of the Know Your Investor series, we are focussing on Alexandria Venture Investments, an integral part of Alexandria Real Estate Equities In 2023, Alexandria Venture Investments invested in 24 companies; 5, 8, 5 & 6 every quarter across 2023 respectively For a detailed report on all the investments, reach out…

ByPrince GiriMay 28, 2024

INSIGHTS+

Know Your Investor (March Edition): Qiming Venture Partners

Shots: In this reprise, we feature Qiming Venture Partners again, based on the investments in 2023. With more than 600 investments to date, Qiming boasts a strong portfolio of companies involved in Technology & Consumer and Healthcare In 2023, Qiming closed 38 funding rounds comprising 11 in the first quarter, 10 in the second, 11…

BySenior EditorMarch 26, 2024

INSIGHTS+

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Shots: The EMA approved 5 BLA and 8 New Chemical Entities in February 2024, leading to treatments for patients and advances in the healthcare industry In February 2024, the major highlighted drugs were Reblozyl to treat Transfusion-Dependent Anemia and Velsipity for the treatment of Severely Active Ulcerative Colitis PharmaShots has compiled a list of a total…

BySenior EditorMarch 20, 2024

Know Your Investor: Surveyor Capital (December’24 Edition)

Know Your Investor: Catalio Capital Management (November’24 Edition)

Know Your Investor: Samsara Biocapital (October’24 Edition)

Know Your Investor: BVF Partners L.P. (September’24 Edition)

Know Your Investor: Arch Venture Partners (August’24 Edition)

Know Your Investor: Invus (July’24 Edition)

Know Your Investor (June Edition): Google Ventures

Know Your Investor (May Edition): Alexandria Venture Investment

Know Your Investor (March Edition): Qiming Venture Partners

Insights+: EMA Marketing Authorization of New Drugs in February 2024

Contact US

OUR INFORMATION

FOLLOW US